Patrick Morgan, MD
Obstetrics & Gynecology · Maryville, TNNPI 1245209733
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $14,874 of the $17,399 with a category attached, or 85.5%. AbbVie accounts for 90.1% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2022 at $15,415 and has fallen 97.7% since, to $352 in 2025. Among obstetrics & gynecology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 154 payments — averaging $112.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$16K
- Sage Therapeutics, LLC$234
- Astellas Pharma US Inc$163
- Caldera Medical, Inc$145
- Mayne Pharma Commercial LLC$141
- Exeltis, USA Inc.$138
- plus $905 from 22 others
What the payments were for
- Speaking & faculty fees$14,87485%
- Food & beverage$2,44514%
- Education$790%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 68 | $15,673 |
| Sage Therapeutics, LLC | 14 | $234 |
| Astellas Pharma US Inc | 9 | $163 |
| Caldera Medical, Inc | 2 | $145 |
| Mayne Pharma Commercial LLC | 10 | $141 |
| Exeltis, USA Inc. | 9 | $138 |
| Intuitive Surgical | 4 | $137 |
| Boston Scientific | 5 | $109 |
| Daiichi Sankyo Inc. | 6 | $108 |
| Agile Therapeutics, Inc. | 4 | $83 |
| Aspira Women's Health Inc | 1 | $64 |
| Myovant Sciences Inc. | 3 | $54 |
| Organon | 2 | $49 |
| Axonics, Inc. | 2 | $42 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| Urovant Sciences Inc | 1 | $22 |
| Sanofi Pasteur Inc. | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Octapharma USA, Inc. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Duchesnay USA Incorporated | 1 | $16 |
| Roche Diagnostics Corporation | 1 | $15 |
| Shield Therapeutics Inc | 1 | $14 |
| Pfizer | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Desara$131
How this compares
$17,399 in reported general payments places this provider in the 95th percentile of 763 obstetrics & gynecology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 14 | $8,803 |
| Estradiol | 68 | $1,711 |
| Solifenacin Succinate | 14 | $583 |
| Oxybutynin Chloride | 18 | $428 |
| Clobetasol Propionate | 21 | $259 |
| Medroxyprogesterone Acetate | 14 | $228 |
| Ibuprofen | 11 | $59 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $163 | $8,80314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 763 obstetrics & gynecology providers in Tennessee.
Other obstetrics & gynecology in Maryville
- Grover MayJohnson City$916K
- John GreenElizabethton$878K
- Brent LaingElizabethton$480K
- Larry FieldsKnoxville$323K
- Michael SwanNashville$146K
- Clarinda Burton-ShannonLebanon$114K
- Royce AdkinsNashville$95K
- Olga MuldoonNashville$91K
- Kimberly LooneyNashville$84K
- Bert GeerCookeville$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.